Bausch Health Companies News and Activities
Presence
Bausch Health Companies develops, makes, and sells medicines and health products. Its main offerings include prescription drugs, eye care products, and dermatology treatments for patients, healthcare professionals, hospitals, and retail customers.
Bausch Health Companies products and services overview:
- Prescription drugs
- Eye care products
- Dermatology treatments
- Gastrointestinal medicines
- Neurology medicines
- Aesthetic devices
Revenue: ~$10 billion
Employees: 21,000
Headquarters: Laval, United States (USA)
Bausch Health Companies is one of the...
Bausch Health Companies is a company listed under the stock ticker BHC (CA).
Bausch Health Companies has a direct presence in 6 countries.Bausch Health Companies has 11 subsidiaries including Bausch & Lomb France, Bausch & Lomb Germany and Bausch & Lomb Italy.
They are in:
Executives
View the org chart displaying its 117 main executives
Most searched biographies at Bausch Health Companies
- Thomas Appio, Chief Executive Officer and Director
- Robert Power, Director
- Richard Mulligan, Director
Create your alert
to follow the executive moves at Bausch Health Companies.
Pharmaceuticals
Bausch Health Companies has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Corden Pharma has announced the acquisition of AmbioPharm (posted on June 5 2026).
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Bausch Health Companies
- Bausch Health Announces 2026 Annual Meeting of Shareholder Results
- Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China
- Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference
- Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference
- Bausch Health Announces First Quarter 2026 Results
- Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering
- Bausch Health to Announce First Quarter 2026 Results on April 29, 2026
- Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program
- Bausch Health Announces 2026 Gastrointestinal Health Scholars Program
- Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
- View more press releases Close
Social media about Bausch Health Companies
- Bausch Health Companies on Wikipedia, Google News & Yahoo Finance
- Bausch Health Companies on LinkedIn, X (Twitter) & YouTube
